Turmeric is a traditional plant ingredient that has been used for centuries, especially in Asian regions, for both culinary and cultural purposes. Recognized for its distinctive yellow color, it has long been valued beyond just its use as a spice.Today, turmeric continues to gain attention in modern science, with growing research highlighting its bioactive compounds and their potential role in supporting health and well-being.
Among these, curcumin is the principal bioactive compound that has attracted significant scientific interest due to its strong anti-inflammatory and antioxidant properties. It contributes to the regulation of inflammation by acting on molecular markers, including cytokines and related signaling pathways, making it relevant in conditions associated with chronic inflammation. Curcumin is also known for its multi-targeted activity, interacting with enzymes, receptors, and other biological molecules, which adds to its functional significance. However, despite its promising properties, its application is limited by low bioavailability, largely due to poor water solubility, rapid degradation, and limited absorption in the body. These challenges have led to increased focus on developing improved formulations to enhance its effectiveness.
In addition to curcumin, turmeric also contains polysaccharides that contribute to its functional benefits. These compounds are recognized for their antioxidant activity, acting as effective free radical scavengers and helping protect against oxidative damage. Since oxidative stress is linked to conditions such as inflammation, metabolic disorders, and cardiovascular diseases, turmeric polysaccharides play a supportive role in maintaining overall health and enhancing the plant’s therapeutic potential.
Turmimax™
Turmimax™ is a clinically evaluated turmeric extract developed by Star Hi Herbs Pvt Ltd, to address the well-known limitations of conventional curcumin. While regular turmeric extracts may offer benefits on paper, their limited solubility often means the body can’t fully utilize them. Turmimax™ is designed to change that. With 100% water dispersibility and up to 35x higher bioavailability, it helps ensure that curcumin is more effectively delivered and absorbed. This not only improves overall performance but also allows formulators to achieve desired results at lower dosages. Supported by scientific studies, Turmimax™ has shown the ability to influence inflammation pathways while maintaining a strong safety profile.
OptiBio™ Bioavailability Assurance
Turmimax™ is designed to ensure optimal bioavailability. Our patented sourcing and manufacturing process, known as OptiBio™, delivers 35 times greater bioavailability compared to standard 95% turmeric.
100% Dispersibility of Turmimax®
Turmimax™ is designed with 100% water dispersibility, allowing it to dissolve quickly and evenly without leaving residue. This ensures consistent absorption and improved stability in aqueous environments. Its superior dispersibility enhances the body’s ability to utilize curcuminoids effectively compared to conventional turmeric extracts.
Anti-inflammatory Activity of Turmimax™
• Significantly reduces IL-8 and IL-12 expression in LPS-stimulated RAW 264.7 macrophage cells compared to untreated inflammatory conditions.
• Controls inflammation at the cellular level by downregulating pro-inflammatory cytokines elevated during LPS-induced responses.
• Demonstrates significant reduction in ear edema in croton oil-induced inflammation, with effects comparable to Diclofenac.
• Shows strong anti-edematous activity by significantly decreasing histamine-induced paw swelling in animal models.
• Reduces inflammation by lowering prostaglandin levels through cyclooxygenase pathway inhibition.
• Suppresses histamine-mediated inflammatory responses through modulation of H1 receptor-related pathways.
• Modulates key inflammatory signaling pathways, including NF-κB, and regulates cytokine expression at the mRNA level.
• Demonstrates consistent anti-inflammatory activity across both in vitro and in vivo models, confirming effectiveness across multiple inflammation pathways.
()
()
Cytotoxicity of Turmimax®
- Turmimax® was tested on Raw 264.7 murine macrophage cells to assess its safety and impact on cell viability.
- The study used the MTT assay, which measures metabolic activity of living cells, providing an indirect indication of cytotoxicity.
- Turmimax® was fully soluble in the culture medium, ensuring accurate testing of its effects.
- At functional doses, Turmimax® showed no cytotoxic effects, demonstrating that it is well-tolerated by macrophage cells.
- Only at very high concentrations did Turmimax® show cytotoxicity, indicating a wide safety margin for practical use.
- This confirms that Turmimax® can be used safely in formulations designed to reduce inflammation or support wellness without harming healthy cells.
- The results highlight the careful design of Turmimax® to maintain cellular safety while delivering potent anti-inflammatory benefits.
()
Turmesac®
Turmesac® is a high-quality turmeric extract crafted for modern nutraceuticals that demand more than a standard ingredient.Using a specialized aqueous extraction process, it preserves a wide range of bioactive compounds, including 10% polysaccharides, resulting in a well-balanced and functional profile. Its blend of bioactive compounds supports multiple health pathways while remaining safe and reliable, making Turmesac® a high-quality ingredient for consistent and effective nutraceutical products.
Cytotoxicity of Turmesac®
- Turmesac® was tested on MCF-7 (breast cancer) and HUH-7 (liver) cell lines using the MTT assay.
- The MTT assay measures cell viability based on mitochondrial activity, with live cells reducing MTT to colored formazan crystals.
- Turmesac® showed significant cytotoxic activity against MCF-7 cells, suggesting its potential as an anticancer agent for breast cancer.
- It did not show cytotoxicity against HUH-7 cells, demonstrating its selective action and safety for normal liver cells.
- Microscopic observation confirmed the reduction in cell viability for cancer cells, supporting the idea that Turmesac® induces cell death in targeted cancer lines.
- These findings highlight Turmesac® as a promising candidate for chemotherapeutic applications.
Cytotoxicity effect of Turmesac against HUH7cell line after 48 h incubation.
Cytotoxicity effect of Turmesac® vs H2O2 treated HUH7cell line after 48 h incubation
()
Anti-Inflammatory Activity of Turmesac®
- Turmesac® significantly reduced inflammation in LPS-stimulated macrophage cells by inhibiting pro-inflammatory cytokines IL-8 and IL-12.
- The study used Raw 264.7 macrophage cells, a standard model to evaluate inflammation.
- Turmesac® modulates inflammatory pathways, reducing NF-κB activity and controlling cytokine expression.
- In preclinical models, Turmesac® effectively reduced edema and tissue swelling, demonstrating measurable anti-inflammatory benefits.
- These effects confirm Turmesac® as a natural compound with strong potential for managing inflammation-related conditions.
Antioxidant Activity of Turmesac®
Turmesac® demonstrates strong antioxidant potential by scavenging free radicals, helping to neutralize harmful oxidative molecules in cells.
Its antioxidant activity was measured using the standard DPPH assay and compared with the reference antioxidant, butylated hydroxytoluene (BHT).
Turmesac® effectively reduced free radicals, showing a significant dose-dependent radical scavenging effect.
While BHT showed higher potency, Turmesac® displayed promising antioxidant activity, supporting its role in protecting cells from oxidative stress.
DPPH free radical scavenging activity (IC50µg/ml) of Turmesac®
(https://journal-backups.lon1.digitaloceanspaces.com/uploads/main/article/1509dc562094.pdf)
Hepatoprotective Activity of Turmesac®
- Turmesac® was tested for hepatoprotective activity by exposing cells to oxidative stress induced by H2O2.
- Cells treated with Turmesac® maintained higher viability, indicating protection against oxidative damage.
- The MTT assay confirmed that Turmesac® helped cells recover from stress, supporting liver cell health.
- These findings suggest Turmesac® can protect liver cells from oxidative damage, making it a promising natural hepatoprotective agent.
Which One Should You Choose?
Choosing between curcumin and turmeric polyphenols depends on your formulation goals and the level of support you want to deliver. Here’s a simple guide:
For Targeted, High-Impact Support:Curcumin is ideal when you’re aiming for focused therapeutic benefits. It is widely used in formulations designed for inflammation management, joint health, metabolic support, and recovery. With its potent antioxidant and bioactive profile, curcumin is best suited for standardized, high-efficacy products where performance is key.
For Daily Wellness and Broad-Spectrum Support:Turmeric polyphenols are better suited for holistic and preventive applications. They provide balanced antioxidant support, immune modulation, and overall wellness benefits, making them ideal for functional foods, beverages, and lifestyle-oriented formulations. Their broader composition allows for smoother integration into daily health products.
Suitable for Various Products
Both Turmimax™ and Turmesac® are ideal for most delivery forms and applications including foods, beverages, shots, gummies, capsules, tablets and more.
About Star Hi Herbs
Star Hi Herbs is a global leader in manufacturing high-quality herbal extracts, nutraceutical ingredients, and botanical solutions for the wellness, personal care, cosmetic, and nutraceutical industries. With a strong foundation in traditional plant knowledge and a commitment to modern science, we deliver safe, consistent, and effective herbal actives that meet international standards.
Our Strengths:
- Extensive cultivation through 30,000 acres of contract farming
- Advanced manufacturing capacity of 6,000 MT per annum
- Over 27 globally registered patents
- More than 20 scientific research publications
- Serving 550+ customers worldwide
- Commitment to ethical sourcing, sustainability, and rigorous quality assurance
- State-of-the-art facilities compliant with ISO, FSSC, GMP, and USDA Organic standards
Conclusion
Turmimax™ and Turmesac® are premium turmeric extracts from Star Hi Herbs, designed to deliver science-backed, highly bioavailable curcumin and turmeric polyphenols for modern nutraceuticals and wellness products. Turmimax™ offers potent anti-inflammatory and antioxidant benefits, supporting joint health, metabolic balance, and targeted therapeutic applications. Turmesac® provides broad-spectrum wellness support with hepatoprotective, antioxidant, and immune-modulating properties. Both extracts are rigorously tested for safety, efficacy, and quality, ensuring reliable performance in functional foods, dietary supplements, and nutraceutical formulations. Backed by advanced extraction technology, patented formulations, and Star Hi Herbs’ commitment to sustainable sourcing and ISO-compliant manufacturing, Turmimax™ and Turmesac® empower formulators to create effective, nature-inspired health solutions that meet global standards.
FAQs:
1. What is Turmimax™?
Turmimax™ is a highly bioavailable turmeric extract with 100% water dispersibility. It delivers curcumin effectively, supporting inflammation management, joint health, and overall wellness.
2. What is Turmesac®?
Turmesac® is a turmeric extract rich in polysaccharides and polyphenols. It provides antioxidant, anti-inflammatory, and liver-protective benefits, making it suitable for daily wellness products.
3. How do they differ?
Turmimax™ offers focused, high-bioavailability curcumin for therapeutic benefits, while Turmesac® provides a broad-spectrum turmeric extract for overall wellness and preventive health.
4. Are these products safe?
Yes. Both have been tested for safety. Turmimax™ is safe for immune cells, and Turmesac® selectively targets cancer cells while being safe for normal liver cells.
5. What are their key benefits?
Turmimax™: Anti-inflammatory, antioxidant, safe at functional doses.
Turmesac®: Anti-inflammatory, antioxidant, hepatoprotective, selective cytotoxicity for cancer cells.
6. Who makes them?
Both are developed by Star Hi Herbs, a global leader in herbal extracts with 30,000 acres of cultivation, 6,000 MT production capacity, 27+ patents, 20+ scientific publications, and 550+ global customers.
References:
- H. M. Firoz , S. Nanjundaiah , C. T. Sadashiva , B. Neethumol , Y. Rashmi and A. K. Sreedrisya. Antiproliferative activity and apoptosis-inducing mechanism of Curcuma longa (Turmimax®) on HeLa cell lines. Brazilian Journal of Biology. 2023, vol. 83, e275953.
- Firoz Hussain H.M., Nanjundaiah S., Sadashiva Channangihalli Thimmegowda, Neethumol Benny and Rashmi Y. Evaluation of anti-inflammatory potential of Turmimax® an in vivo and in vitro study. American Journal of Biochemistry and Biotechnology, Volume 18 (4) 2022, 386-393.
- In vitro anti-inflammatory and hepatoprotective activity of turmesac®. Firoz H. M., Nanjundaiah S., Sadashiva C. T. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 12, no. 9, Sept.2020, pp. 49-53,
- Firoz H.M, Nanjundaiah S, Sadashiva C.T*. Evaluation of the anticancer properties of turmesac® in human cervical adenocarcinoma. Asian j pharm clin res, vol 13, issue 5, 2020, 109-113.
- C. T. Sadashiva*, H. M. Firoz hussain and S. Nanjundaiah. Evaluation of hepatoprotective, antioxidant and cytotoxic properties of aqueous extract of turmeric rhizome (turmesac®). J. Med. Plants res. Vol. 13(17), pp. 423-430, october, 2019
- C. T. Sadashiva*, H.M. Firoz hussain and S. Nanjundaiah. Ejbps, 2020, volume 7, issue 2, 402-409. Pharmacological evaluation of hepatoprotective activity of turmesac® on paracetamol-induced liver toxicity in rats.
- McCaleb, R., Leigh, E., & Morien, K. Turmeric, Curcuma longa, Zingiberaceae. The Encyclopedia of Popular Herbs, (2000), 374-381.
- Trinidad, P. T., Sagum, R. S., de Leon, M. P., Mallillin, A. C., & Borlagdan, M. P. Zingiber officinale and Curcuma longa as potential functional foods/ingredients. Food and Public Health, (2012), 2(2), 1-4.
- Sankireddy, S., Mittal, S., Vinayak, V. Curcumin-a Solid Gold in Medicine and Dentistry. Indian Journal of Public Health Research & Development. (2015), 6(3).
- Asish, K.D., Elizabeth, I. Novel drug delivery systems to improve bioavailability of Curcumin. Journal of bioequivalence and bioavailability. (2013), 6(1):1-9.
- Srimal, R.C. Turmeric: a brief review of medicinal properties. Fitoterapia. (1997), 68(6):483-493.
- Choi, W.Y., Lee, H.Y. Enhancement of Antioxidant Activities of Curcuma longa Leaves by Ultra High Pressure Extraction. Korean J.Med. Crop Sci. (2014), 22: 121–126.
- Gupta, S.C., Patchva, S., Aggarwal, B.B. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS J. (2013), 15:195–218.
- Aggarwal, B.B., Harikumar, K.B. Potential therapeutic effects of curcumin, the anti- inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. (2009), 41:40–59.
- Aggarwal, B.B., Kumar, A., Bharti, A.C. Anticancer potential of curcumin: Preclinicaland clinical studies. Anticancer Res. (2003), 23:363–398.
- Mahady, G.B., Pendland, S.L., Yun, G., Lu, Z.Z. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. AnticancerRes. (2002), 22:4179–4181.
- Vera-Ramirez, L., Perez-Lopez, P., Varela-Lopez, A., Ramirez-Tortosa, M., Battino, M.,Quiles, J.L. Curcumin and liver disease. Biofactors. (2013), 39:88–100.
- Alizadeh, M., Kheirouri, S. Curcumin reduces malondialdehyde and improves antioxidants in humans with diseased conditions: A comprehensive meta-analysis of randomized controlled trials. BioMedicine (2019), 9.
- Tan, B.L., Norhaizan, M.E., Liew, W.-P., Rahman, H.S. Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases. Front. Pharmacol. (2018), 9, 1162.
- Ghosh, S., Banerjee, S., Sil, P.C. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol. (2015), 83:111-124.
- Hidaka, H., Ishiko, T., Furuhashi, T., Kamohara, H., Suzuki, S., Miyazaki, M., Ikeda, O., Mita, S., Setoguchi, T., Ogawa, M. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: Impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer. (2002), 95, 1206– 1214.
- Jain, S.K., Rains, J., Croad, J., Larson, B., Jones, K. Curcumin Supplementation Lowers TNF-α, IL-6, IL-8, and MCP-1 Secretion in High Glucose-Treated Cultured Monocytes and Blood Levels of TNF-α, IL-6, MCP-1, Glucose, and Glycosylated Hemoglobin in Diabetic Rats. Antioxidants Redox Signal. (2009), 11, 241–249.
- Lawrence, C., Nauciel, C. Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan. Infect. Immun. (1998), 66:4947–4949.
- Trinchieri, G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. (1998), 70:83–243.
- Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. (2007), 4:807–818.
- Heger, M., van Golen, R.F., Broekgaarden, M., Michel, M.C. The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer. Pharmacol. Rev. (2013), 66:222-307.
- Memarzia, A., Khazdair, M.R., Behrouz, S., Gholamnezhad, Z., Jafarnezhad, M., Saadat, S., Boskabadi, M.H. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review. BioFactors. (2021), 47:311–50.
- Aoshima, H., Tsunoue, H., Koda, H. Aging of whiskey increases 1, 1- diphenyl-2- picrylhydrazyl radical scavenging activity. J. Agric. Food Chem. (2004), 52:5240–5244.
- Tomeh, M.A., Hadianamrei, R., Zhao, X. A Review of Curcumin and Its Derivatives asAnticancer Agents. Int J Mol Sci. (2019), 20 (5):1033.
- Ojo, O.A., Adeyemo, T.R., Rotimi, D., Batiha, G.E., Mostafa-Hedeab, G., Iyobhebhe, M.E., Elebiyo, T.C., Atunwa, B., Ojo, A.B., Lima, C.M.G., Conte-Junior, C.A. Anticancer Properties of Curcumin Against Colorectal Cancer: A Review. Front Oncol. (2022), 12:881641.
- Sethi, G., Tergaonkar, V. Potential pharmacological control of the NF-κB pathway. Trends Pharmacol Sci. (2009), 30(6):313-21.
- Giordano, A., Tommonaro, G. Curcumin and Cancer. Nutrients. (2019), 11 (10):2376.
- Wua, S., Jui-Chiang, Lee, Cheng, Kuei-Jen, Yu-Ming, Sun. Docking Prediction for Tumor Necrosis Factor- α and Five Herbal Inhibitors. International Journal of Engineering Science and Technology. (2010), 2(9).
- Salem, Melissa, Rohani, Sohrab, Gillies, Elizabeth. Curcumin, a Promising AnticancerTherapeutic: A Review of Its Chemical Properties, Bioactivity, and Approaches to Cancer Cell Delivery. RSC Advances. (2014), 4:10815-10829.
